Rare diseases
Investigational molecules
Locations
Back to Hungary62 clinical trials in Szombathely, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
HungaryLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
HungaryStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
HungaryStudy on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
HungaryStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
HungaryLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
HungaryEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
HungaryEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
HungaryEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
HungaryGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
HungaryA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
HungaryStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory conditions, particularly investigating new treatments for asthma and COPD. Studies evaluate innovative therapies including atuliflapon and dupilumab for improving lung function and disease control.
Research aims to enhance therapeutic options for patients with uncontrolled respiratory conditions.
Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa.
Studies focus on developing targeted treatments for chronic inflammatory conditions.
Groundbreaking research in cancer treatment and blood disorders, including studies on breast cancer, lymphoma, and multiple myeloma. Investigations of targeted therapies and combination treatments.
Focus on improving survival rates and treatment outcomes in various cancer types.
Clinical research examining treatments for inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Evaluation of combination therapies and novel biological agents.
Emphasis on improving quality of life for patients with chronic digestive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
